Tenvie Therapeutics
PrivateLast Round
Series A
Jan 8, 2025
Total Funding Raised
$200M
Company Overview
Tenvie Therapeutics operates in Healthcare & Life Sciences and is based in South San Francisco, California. Its latest recorded funding round was a Series A round in January 2025.
Tenvie Therapeutics is a biotechnology company that develops a platform of small molecule therapies for treating neurological, cardiometabolic, and ophthalmic diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Infrastructure
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Tenvie Therapeutics Comparables
Compare Tenvie Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Nura Bio | 85% | |
| Sironax | 84% | |
| Ventus Therapeutics | 84% |
For institutional investors. Book with your work email.
Tenvie Therapeutics Funding Rounds
Historical fundraising activity
For institutional investors. Book with your work email.
Tenvie Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| F-Prime Capital | Series A |
| ARCH Venture Partners | Series A |
| Mubadala Capital | Series A |
| F-Prime Capital | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 1, 2026
Grew 17% QoQ, from 42 to 49 employees.
- Apr 19, 2026
Monthly visitors increased 68% MoM.
For institutional investors. Book with your work email.
Tenvie Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Tenvie Therapeutics's valuation, stock price, and market status.
Is Tenvie Therapeutics a public or private company?
Tenvie Therapeutics is a private company.
What is the current stock price of Tenvie Therapeutics?
Tenvie Therapeutics is a private company, so its shares have no public market price. Caplight tracks Tenvie Therapeutics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Tenvie Therapeutics worth (valuation)?
Valuation information for Tenvie Therapeutics is not publicly available.
Can I buy Tenvie Therapeutics stock?
Tenvie Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Tenvie Therapeutics's last funding round?
Tenvie Therapeutics's most recent funding round was Series A on January 8, 2025.
Who are the main investors in Tenvie Therapeutics?
Key investors in Tenvie Therapeutics include F-Prime Capital, ARCH Venture Partners, Mubadala Capital, F-Prime Capital.
Will Tenvie Therapeutics IPO soon?
No public IPO plans have been announced for Tenvie Therapeutics.
How can I track Tenvie Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades in Tenvie Therapeutics's shares on secondary markets.